Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ahr
|
ENSMUSG00000019256.11 | aryl-hydrocarbon receptor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_35534028_35535328 | Ahr | 55 | 0.760176 | 0.54 | 6.9e-06 | Click! |
chr12_35527310_35527461 | Ahr | 606 | 0.712652 | -0.41 | 1.2e-03 | Click! |
chr12_35530431_35530582 | Ahr | 3727 | 0.198893 | -0.23 | 8.1e-02 | Click! |
chr12_35503909_35504469 | Ahr | 22590 | 0.160226 | 0.15 | 2.5e-01 | Click! |
chr12_35529646_35529935 | Ahr | 3011 | 0.222469 | -0.10 | 4.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_89622321_89623623 | 20.33 |
Minar1 |
membrane integral NOTCH2 associated receptor 1 |
153 |
0.95 |
chr13_58807413_58808951 | 16.13 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
99 |
0.95 |
chr9_89909468_89909807 | 15.13 |
Rasgrf1 |
RAS protein-specific guanine nucleotide-releasing factor 1 |
271 |
0.93 |
chr7_16946370_16947636 | 14.80 |
Pnmal2 |
PNMA-like 2 |
2321 |
0.14 |
chr1_42684511_42685482 | 14.41 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
8097 |
0.14 |
chr1_5916517_5917959 | 13.65 |
Npbwr1 |
neuropeptides B/W receptor 1 |
160 |
0.97 |
chr13_78194785_78195954 | 13.37 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
1004 |
0.42 |
chr7_44336079_44337576 | 13.34 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
811 |
0.34 |
chr18_80295599_80296556 | 12.97 |
Gm37015 |
predicted gene, 37015 |
7603 |
0.13 |
chr12_112928468_112928791 | 12.68 |
Jag2 |
jagged 2 |
181 |
0.89 |
chr15_103503210_103504096 | 12.25 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
376 |
0.81 |
chr17_55445302_55446500 | 12.22 |
St6gal2 |
beta galactoside alpha 2,6 sialyltransferase 2 |
343 |
0.91 |
chr17_48932346_48933546 | 12.17 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
567 |
0.85 |
chr17_17849706_17850672 | 11.78 |
Has1 |
hyaluronan synthase 1 |
4999 |
0.1 |
chr13_51594475_51595717 | 11.76 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
25609 |
0.16 |
chr4_42670348_42671327 | 11.74 |
Il11ra2 |
interleukin 11 receptor, alpha chain 2 |
5074 |
0.14 |
chr19_7612123_7612981 | 11.71 |
Plaat5 |
phospholipase A and acyltransferase 5 |
3 |
0.97 |
chr4_42173585_42174168 | 11.44 |
1700045I11Rik |
RIKEN cDNA 1700045I11 gene |
3031 |
0.11 |
chr7_16948034_16948663 | 11.33 |
Pnmal2 |
PNMA-like 2 |
3666 |
0.11 |
chr19_48205036_48205839 | 11.32 |
Sorcs3 |
sortilin-related VPS10 domain containing receptor 3 |
588 |
0.8 |
chrX_73823460_73823611 | 11.25 |
Pdzd4 |
PDZ domain containing 4 |
1434 |
0.24 |
chr2_156421041_156421868 | 11.24 |
Epb41l1 |
erythrocyte membrane protein band 4.1 like 1 |
342 |
0.76 |
chr11_68384940_68385629 | 11.19 |
Ntn1 |
netrin 1 |
1542 |
0.44 |
chr16_94124910_94125992 | 11.17 |
Sim2 |
single-minded family bHLH transcription factor 2 |
270 |
0.88 |
chr5_36868663_36870303 | 11.13 |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
820 |
0.55 |
chr8_12385818_12386491 | 11.12 |
Sox1ot |
Sox1 overlapping transcript |
383 |
0.8 |
chr11_118908287_118909561 | 10.99 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
626 |
0.73 |
chr2_24762271_24763479 | 10.94 |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
172 |
0.95 |
chr13_58806621_58807262 | 10.88 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
302 |
0.85 |
chr17_47877478_47879368 | 10.86 |
Foxp4 |
forkhead box P4 |
530 |
0.7 |
chr4_130792618_130793447 | 10.76 |
Sdc3 |
syndecan 3 |
328 |
0.8 |
chr6_101198088_101199306 | 10.74 |
Gm26911 |
predicted gene, 26911 |
39 |
0.89 |
chrX_6091588_6092836 | 10.39 |
Gm26618 |
predicted gene, 26618 |
57 |
0.96 |
chr7_5056231_5057716 | 10.36 |
Gm15510 |
predicted gene 15510 |
53 |
0.48 |
chr1_18057820_18058958 | 10.36 |
Gm45784 |
predicted gene 45784 |
120 |
0.8 |
chr8_11187747_11188818 | 10.32 |
Gm15418 |
predicted gene 15418 |
527 |
0.75 |
chr18_31446492_31447667 | 10.28 |
Syt4 |
synaptotagmin IV |
327 |
0.87 |
chr6_145048452_145048971 | 10.27 |
Bcat1 |
branched chain aminotransferase 1, cytosolic |
101 |
0.93 |
chr2_164485964_164486468 | 10.22 |
Dbndd2 |
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
110 |
0.92 |
chr1_152955506_152956322 | 10.15 |
Nmnat2 |
nicotinamide nucleotide adenylyltransferase 2 |
640 |
0.67 |
chr4_20777578_20779035 | 10.02 |
Nkain3 |
Na+/K+ transporting ATPase interacting 3 |
261 |
0.96 |
chr7_37768924_37769455 | 10.00 |
Zfp536 |
zinc finger protein 536 |
435 |
0.87 |
chr3_107516925_107518261 | 9.85 |
Slc6a17 |
solute carrier family 6 (neurotransmitter transporter), member 17 |
156 |
0.95 |
chr1_189342678_189343152 | 9.82 |
Kcnk2 |
potassium channel, subfamily K, member 2 |
440 |
0.52 |
chr15_95527528_95528774 | 9.69 |
Nell2 |
NEL-like 2 |
27 |
0.99 |
chr2_26628014_26629340 | 9.64 |
Dipk1b |
divergent protein kinase domain 1B |
183 |
0.88 |
chr6_136172206_136173574 | 9.58 |
Gm26653 |
predicted gene, 26653 |
171 |
0.59 |
chr2_158611997_158612747 | 9.52 |
Gm14205 |
predicted gene 14205 |
552 |
0.57 |
chr8_70087638_70088783 | 9.46 |
Hapln4 |
hyaluronan and proteoglycan link protein 4 |
4066 |
0.1 |
chr11_105292145_105293042 | 9.45 |
Mrc2 |
mannose receptor, C type 2 |
50 |
0.98 |
chr10_114801427_114802496 | 9.43 |
Gm15723 |
predicted gene 15723 |
235 |
0.62 |
chr15_92396719_92397935 | 9.43 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
446 |
0.89 |
chr13_51566607_51568077 | 9.42 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
258 |
0.94 |
chr5_117241784_117242411 | 9.34 |
Taok3 |
TAO kinase 3 |
1637 |
0.3 |
chr11_98325707_98326374 | 9.26 |
Neurod2 |
neurogenic differentiation 2 |
3608 |
0.12 |
chr4_41694325_41694964 | 9.25 |
Cntfr |
ciliary neurotrophic factor receptor |
798 |
0.43 |
chr15_87544354_87545329 | 9.20 |
Tafa5 |
TAFA chemokine like family member 5 |
542 |
0.87 |
chr15_83779433_83779836 | 9.15 |
Mpped1 |
metallophosphoesterase domain containing 1 |
167 |
0.96 |
chr14_13283913_13285295 | 9.14 |
Gm5087 |
predicted gene 5087 |
26 |
0.69 |
chr12_29527051_29527810 | 9.10 |
Myt1l |
myelin transcription factor 1-like |
954 |
0.62 |
chr4_25799045_25800424 | 9.02 |
Fut9 |
fucosyltransferase 9 |
121 |
0.96 |
chr4_148951648_148952306 | 9.00 |
Gm13205 |
predicted gene 13205 |
3063 |
0.2 |
chr3_55242295_55243824 | 8.99 |
Dclk1 |
doublecortin-like kinase 1 |
533 |
0.78 |
chr12_27338723_27339386 | 8.99 |
Sox11 |
SRY (sex determining region Y)-box 11 |
3520 |
0.35 |
chr14_4182195_4183376 | 8.86 |
Gm2974 |
predicted gene 2974 |
209 |
0.91 |
chr16_5884597_5886147 | 8.85 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr1_87475065_87476008 | 8.78 |
Snorc |
secondary ossification center associated regulator of chondrocyte maturation |
2997 |
0.17 |
chr1_38835637_38836715 | 8.76 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
198 |
0.94 |
chr6_110645148_110646464 | 8.74 |
Gm20387 |
predicted gene 20387 |
110 |
0.67 |
chrX_155624379_155625097 | 8.72 |
Gm15155 |
predicted gene 15155 |
3 |
0.95 |
chr14_4855192_4856263 | 8.71 |
Gm3264 |
predicted gene 3264 |
151 |
0.94 |
chr7_45785007_45785158 | 8.70 |
Lmtk3 |
lemur tyrosine kinase 3 |
298 |
0.53 |
chr11_74589375_74590721 | 8.67 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
76 |
0.97 |
chr6_91839314_91839560 | 8.58 |
Grip2 |
glutamate receptor interacting protein 2 |
12187 |
0.16 |
chr4_148286849_148288201 | 8.54 |
Disp3 |
dispatched RND transporter family member 3 |
440 |
0.81 |
chr4_124658022_124658495 | 8.54 |
Gm2164 |
predicted gene 2164 |
1089 |
0.31 |
chr3_156560544_156561185 | 8.53 |
4930570G19Rik |
RIKEN cDNA 4930570G19 gene |
718 |
0.52 |
chr7_121391567_121393161 | 8.50 |
Hs3st2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
74 |
0.93 |
chr13_42709652_42710400 | 8.48 |
Phactr1 |
phosphatase and actin regulator 1 |
445 |
0.88 |
chr1_23763029_23763470 | 8.46 |
B3gat2 |
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) |
1238 |
0.59 |
chr6_144209950_144210789 | 8.41 |
Sox5 |
SRY (sex determining region Y)-box 5 |
801 |
0.78 |
chr18_62323543_62324195 | 8.38 |
Htr4 |
5 hydroxytryptamine (serotonin) receptor 4 |
335 |
0.93 |
chr6_64799057_64799968 | 8.37 |
Atoh1 |
atonal bHLH transcription factor 1 |
70387 |
0.11 |
chr18_62924070_62924646 | 8.34 |
Apcdd1 |
adenomatosis polyposis coli down-regulated 1 |
1852 |
0.32 |
chr3_27371157_27372632 | 8.29 |
Ghsr |
growth hormone secretagogue receptor |
543 |
0.81 |
chr19_22447648_22448999 | 8.28 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
91 |
0.63 |
chr18_23309850_23311104 | 8.26 |
Gm7788 |
predicted gene 7788 |
93808 |
0.08 |
chr10_109008310_109009456 | 8.25 |
Syt1 |
synaptotagmin I |
217 |
0.96 |
chr11_37235809_37236346 | 8.24 |
Tenm2 |
teneurin transmembrane protein 2 |
113 |
0.98 |
chr4_45825879_45827166 | 8.23 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
401 |
0.81 |
chr14_4110158_4111243 | 8.22 |
Gm8108 |
predicted gene 8108 |
174 |
0.93 |
chr17_45522703_45523906 | 8.22 |
Tcte1 |
t-complex-associated testis expressed 1 |
130 |
0.93 |
chr4_154855596_154856670 | 8.20 |
Ttc34 |
tetratricopeptide repeat domain 34 |
67 |
0.96 |
chr8_17534365_17535810 | 8.18 |
Csmd1 |
CUB and Sushi multiple domains 1 |
194 |
0.97 |
chr7_141434084_141434641 | 8.17 |
Slc25a22 |
solute carrier family 25 (mitochondrial carrier, glutamate), member 22 |
33 |
0.92 |
chr19_28834537_28835875 | 8.14 |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
71 |
0.97 |
chr4_73790300_73791129 | 8.09 |
Rasef |
RAS and EF hand domain containing |
5 |
0.91 |
chr11_64520049_64520796 | 8.07 |
Gm24275 |
predicted gene, 24275 |
70218 |
0.12 |
chr14_4726384_4727541 | 8.05 |
Gm3252 |
predicted gene 3252 |
187 |
0.91 |
chr17_37196656_37197851 | 8.00 |
Olfr94 |
olfactory receptor 94 |
758 |
0.35 |
chr19_59074782_59076053 | 7.98 |
Shtn1 |
shootin 1 |
652 |
0.71 |
chr3_8509825_8511666 | 7.95 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr5_9724633_9726223 | 7.92 |
Grm3 |
glutamate receptor, metabotropic 3 |
258 |
0.93 |
chr10_67912148_67912991 | 7.92 |
Zfp365 |
zinc finger protein 365 |
93 |
0.97 |
chr8_123891512_123893657 | 7.86 |
Acta1 |
actin, alpha 1, skeletal muscle |
2167 |
0.16 |
chr3_13472761_13473581 | 7.86 |
Ralyl |
RALY RNA binding protein-like |
49 |
0.97 |
chr14_79768163_79769199 | 7.85 |
Gm9748 |
predicted gene 9748 |
1227 |
0.37 |
chr8_31089411_31091663 | 7.83 |
Dusp26 |
dual specificity phosphatase 26 (putative) |
733 |
0.65 |
chr8_15010956_15012187 | 7.81 |
Kbtbd11 |
kelch repeat and BTB (POZ) domain containing 11 |
265 |
0.85 |
chr11_97573801_97574201 | 7.79 |
Srcin1 |
SRC kinase signaling inhibitor 1 |
46 |
0.96 |
chr1_184997307_184998530 | 7.78 |
Mark1 |
MAP/microtubule affinity regulating kinase 1 |
1557 |
0.41 |
chr3_97887925_97889043 | 7.78 |
Pde4dip |
phosphodiesterase 4D interacting protein (myomegalin) |
223 |
0.92 |
chr19_5653938_5655278 | 7.76 |
Sipa1 |
signal-induced proliferation associated gene 1 |
229 |
0.82 |
chr6_105676979_105678296 | 7.74 |
Cntn4 |
contactin 4 |
23 |
0.52 |
chr15_74487062_74488275 | 7.74 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
28527 |
0.16 |
chr14_4498814_4499998 | 7.72 |
Gm3173 |
predicted gene 3173 |
15352 |
0.11 |
chr16_60605121_60606481 | 7.70 |
Gm9017 |
predicted gene 9017 |
46 |
0.78 |
chr2_162661151_162661382 | 7.65 |
9430021M05Rik |
RIKEN cDNA 9430021M05 gene |
103 |
0.52 |
chr5_28466220_28467111 | 7.62 |
9530036O11Rik |
RIKEN cDNA 9530036O11Rik |
319 |
0.7 |
chr4_49844475_49845850 | 7.60 |
Grin3a |
glutamate receptor ionotropic, NMDA3A |
387 |
0.91 |
chr7_99267573_99269343 | 7.59 |
Map6 |
microtubule-associated protein 6 |
52 |
0.95 |
chr11_114791349_114792572 | 7.59 |
Btbd17 |
BTB (POZ) domain containing 17 |
3913 |
0.15 |
chr18_15062554_15062878 | 7.56 |
Kctd1 |
potassium channel tetramerisation domain containing 1 |
827 |
0.68 |
chr9_121777534_121778713 | 7.55 |
Gm47108 |
predicted gene, 47108 |
23 |
0.86 |
chr2_96317494_96318819 | 7.54 |
Lrrc4c |
leucine rich repeat containing 4C |
13 |
0.99 |
chr6_22875139_22876535 | 7.54 |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
60 |
0.98 |
chr13_54950296_54950610 | 7.51 |
Unc5a |
unc-5 netrin receptor A |
1042 |
0.46 |
chr8_48555253_48556125 | 7.49 |
Tenm3 |
teneurin transmembrane protein 3 |
157 |
0.97 |
chr13_96130949_96131570 | 7.48 |
Sv2c |
synaptic vesicle glycoprotein 2c |
1318 |
0.36 |
chr16_28752596_28753856 | 7.48 |
Fgf12 |
fibroblast growth factor 12 |
158 |
0.97 |
chr11_63889023_63889728 | 7.47 |
Hs3st3b1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 |
32915 |
0.16 |
chr6_106118323_106119355 | 7.47 |
Cntn4 |
contactin 4 |
74 |
0.99 |
chr7_48958571_48959910 | 7.46 |
Nav2 |
neuron navigator 2 |
143 |
0.95 |
chr10_32889495_32890861 | 7.44 |
Nkain2 |
Na+/K+ transporting ATPase interacting 2 |
283 |
0.94 |
chr6_115136319_115136531 | 7.43 |
Syn2 |
synapsin II |
1475 |
0.27 |
chr5_26817077_26818245 | 7.43 |
Dpp6 |
dipeptidylpeptidase 6 |
227 |
0.94 |
chr13_88821448_88822708 | 7.41 |
Edil3 |
EGF-like repeats and discoidin I-like domains 3 |
436 |
0.91 |
chr4_41695169_41695440 | 7.41 |
Cntfr |
ciliary neurotrophic factor receptor |
138 |
0.91 |
chr12_29533001_29533958 | 7.40 |
Myt1l |
myelin transcription factor 1-like |
94 |
0.96 |
chr16_67617739_67618070 | 7.40 |
Cadm2 |
cell adhesion molecule 2 |
2589 |
0.35 |
chr15_78717021_78717410 | 7.36 |
Elfn2 |
leucine rich repeat and fibronectin type III, extracellular 2 |
898 |
0.51 |
chr3_17793389_17793789 | 7.36 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
331 |
0.86 |
chr4_36950134_36952137 | 7.36 |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
88 |
0.97 |
chr11_35797548_35798866 | 7.35 |
Fbll1 |
fibrillarin-like 1 |
677 |
0.62 |
chrX_101300533_101300752 | 7.33 |
Nlgn3 |
neuroligin 3 |
168 |
0.9 |
chr7_122670691_122671255 | 7.33 |
Cacng3 |
calcium channel, voltage-dependent, gamma subunit 3 |
418 |
0.85 |
chr13_74259471_74260645 | 7.31 |
Ahrr |
aryl-hydrocarbon receptor repressor |
614 |
0.68 |
chr5_135248496_135249658 | 7.31 |
Fzd9 |
frizzled class receptor 9 |
2153 |
0.21 |
chr5_45449715_45450170 | 7.30 |
Qdpr |
quinoid dihydropteridine reductase |
23 |
0.96 |
chr14_64588312_64589438 | 7.28 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
341 |
0.81 |
chr6_86028425_86029744 | 7.21 |
Add2 |
adducin 2 (beta) |
337 |
0.8 |
chr10_81257208_81258396 | 7.20 |
Matk |
megakaryocyte-associated tyrosine kinase |
28 |
0.92 |
chr11_12025582_12027083 | 7.19 |
Grb10 |
growth factor receptor bound protein 10 |
8 |
0.98 |
chr14_5812168_5813063 | 7.17 |
Gm3383 |
predicted gene 3383 |
4633 |
0.14 |
chr8_10153572_10154812 | 7.16 |
Myo16 |
myosin XVI |
224 |
0.95 |
chr15_88954196_88955264 | 7.13 |
Ttll8 |
tubulin tyrosine ligase-like family, member 8 |
312 |
0.84 |
chr14_3571642_3572719 | 7.10 |
Gm3005 |
predicted gene 3005 |
157 |
0.94 |
chr7_79504311_79505700 | 7.06 |
Mir9-3 |
microRNA 9-3 |
259 |
0.82 |
chr13_88822801_88824341 | 7.04 |
Edil3 |
EGF-like repeats and discoidin I-like domains 3 |
1929 |
0.5 |
chr9_102353147_102354512 | 7.03 |
Ephb1 |
Eph receptor B1 |
864 |
0.59 |
chr7_47131990_47133329 | 7.03 |
Ptpn5 |
protein tyrosine phosphatase, non-receptor type 5 |
58 |
0.96 |
chr14_70079421_70080436 | 7.01 |
Egr3 |
early growth response 3 |
1189 |
0.41 |
chr12_61523440_61524787 | 7.01 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
165 |
0.95 |
chr17_71782384_71783600 | 7.01 |
Clip4 |
CAP-GLY domain containing linker protein family, member 4 |
375 |
0.84 |
chr6_93715774_93716464 | 6.95 |
Gm7812 |
predicted gene 7812 |
65894 |
0.11 |
chr5_47984794_47986445 | 6.95 |
Slit2 |
slit guidance ligand 2 |
625 |
0.68 |
chr11_120047221_120047929 | 6.93 |
Aatk |
apoptosis-associated tyrosine kinase |
408 |
0.71 |
chr9_117871858_117873400 | 6.91 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
45 |
0.91 |
chr16_35541254_35542334 | 6.91 |
Sema5b |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B |
223 |
0.92 |
chr5_25768817_25769129 | 6.91 |
Actr3b |
ARP3 actin-related protein 3B |
8934 |
0.19 |
chr5_121828742_121829564 | 6.91 |
Sh2b3 |
SH2B adaptor protein 3 |
412 |
0.73 |
chr13_83741336_83742027 | 6.91 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2818 |
0.16 |
chrX_101085970_101086202 | 6.88 |
Slc7a3 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 |
66 |
0.96 |
chr3_68573207_68574269 | 6.86 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chr1_24586352_24587593 | 6.82 |
Col19a1 |
collagen, type XIX, alpha 1 |
439 |
0.7 |
chr1_53706547_53707373 | 6.81 |
Dnah7a |
dynein, axonemal, heavy chain 7A |
176 |
0.96 |
chr10_106469274_106469516 | 6.81 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
944 |
0.59 |
chr4_45824847_45825701 | 6.80 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
1649 |
0.31 |
chr14_64589664_64590503 | 6.80 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
388 |
0.55 |
chr6_51432956_51433889 | 6.77 |
Nfe2l3 |
nuclear factor, erythroid derived 2, like 3 |
673 |
0.66 |
chr1_12991432_12992703 | 6.77 |
Slco5a1 |
solute carrier organic anion transporter family, member 5A1 |
583 |
0.78 |
chr2_65848718_65849208 | 6.76 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
3108 |
0.27 |
chr14_3809696_3810741 | 6.76 |
Gm3002 |
predicted gene 3002 |
144 |
0.94 |
chr19_5297797_5299076 | 6.72 |
Gal3st3 |
galactose-3-O-sulfotransferase 3 |
105 |
0.9 |
chr10_4711863_4713003 | 6.72 |
Esr1 |
estrogen receptor 1 (alpha) |
218 |
0.96 |
chr3_158559356_158560580 | 6.71 |
Lrrc7 |
leucine rich repeat containing 7 |
1368 |
0.57 |
chr8_121651047_121652249 | 6.71 |
Zcchc14 |
zinc finger, CCHC domain containing 14 |
1253 |
0.31 |
chr4_42173203_42173539 | 6.71 |
1700045I11Rik |
RIKEN cDNA 1700045I11 gene |
2526 |
0.13 |
chr6_48628821_48630012 | 6.70 |
AI854703 |
expressed sequence AI854703 |
1481 |
0.18 |
chr10_41070697_41071486 | 6.70 |
Gpr6 |
G protein-coupled receptor 6 |
1194 |
0.41 |
chr1_119420327_119420935 | 6.69 |
Inhbb |
inhibin beta-B |
1617 |
0.38 |
chr1_89455527_89455950 | 6.68 |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
482 |
0.82 |
chr3_38892303_38893788 | 6.68 |
Fat4 |
FAT atypical cadherin 4 |
2103 |
0.36 |
chr9_87015230_87016430 | 6.67 |
Ripply2 |
ripply transcriptional repressor 2 |
194 |
0.94 |
chr13_9277331_9277900 | 6.67 |
Dip2c |
disco interacting protein 2 homolog C |
633 |
0.61 |
chr10_105574755_105575368 | 6.64 |
Gm15663 |
predicted gene 15663 |
502 |
0.51 |
chr7_45784257_45784949 | 6.62 |
Sult2b1 |
sulfotransferase family, cytosolic, 2B, member 1 |
66 |
0.88 |
chr7_27445809_27447233 | 6.60 |
Sptbn4 |
spectrin beta, non-erythrocytic 4 |
4 |
0.94 |
chr6_51591921_51593175 | 6.60 |
Gm22914 |
predicted gene, 22914 |
29084 |
0.18 |
chr8_71670829_71671681 | 6.59 |
Unc13a |
unc-13 homolog A |
481 |
0.62 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 21.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
5.9 | 17.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
5.5 | 27.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
5.4 | 21.5 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
5.3 | 15.9 | GO:0021856 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
5.3 | 26.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
5.1 | 15.3 | GO:0033058 | directional locomotion(GO:0033058) |
5.0 | 19.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
4.8 | 14.5 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
4.7 | 32.7 | GO:0097264 | self proteolysis(GO:0097264) |
4.3 | 17.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
4.3 | 25.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
4.2 | 17.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
4.2 | 8.4 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
4.2 | 25.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
3.9 | 7.9 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
3.9 | 11.6 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
3.9 | 11.6 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
3.6 | 35.9 | GO:0071625 | vocalization behavior(GO:0071625) |
3.6 | 3.6 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
3.5 | 17.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
3.4 | 3.4 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
3.4 | 6.7 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
3.3 | 13.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
3.3 | 13.0 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
3.2 | 3.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
3.1 | 12.6 | GO:0060437 | lung growth(GO:0060437) |
3.1 | 9.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
3.1 | 9.3 | GO:0060174 | limb bud formation(GO:0060174) |
3.1 | 3.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.1 | 24.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
3.0 | 9.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
3.0 | 15.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
3.0 | 9.0 | GO:0021586 | pons maturation(GO:0021586) |
2.9 | 2.9 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
2.9 | 2.9 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
2.8 | 8.5 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
2.8 | 5.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
2.8 | 11.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
2.8 | 8.4 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
2.8 | 5.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
2.7 | 10.8 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
2.7 | 2.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
2.7 | 13.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
2.6 | 7.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.6 | 5.3 | GO:0014016 | neuroblast differentiation(GO:0014016) |
2.6 | 5.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
2.6 | 10.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.6 | 13.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
2.6 | 25.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
2.6 | 7.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.6 | 20.5 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
2.5 | 5.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
2.5 | 7.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
2.5 | 7.4 | GO:0030070 | insulin processing(GO:0030070) |
2.4 | 7.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
2.4 | 7.3 | GO:0032898 | neurotrophin production(GO:0032898) |
2.4 | 16.9 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
2.4 | 9.6 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
2.4 | 16.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.3 | 7.0 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
2.3 | 7.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
2.3 | 7.0 | GO:0008355 | olfactory learning(GO:0008355) |
2.3 | 11.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
2.3 | 7.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
2.2 | 6.7 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
2.2 | 15.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
2.2 | 17.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
2.2 | 4.4 | GO:0050975 | sensory perception of touch(GO:0050975) |
2.2 | 6.5 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
2.1 | 8.5 | GO:0030035 | microspike assembly(GO:0030035) |
2.1 | 8.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
2.1 | 6.3 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
2.0 | 18.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.0 | 32.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
2.0 | 6.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
2.0 | 4.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
2.0 | 6.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
2.0 | 6.0 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
2.0 | 8.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
2.0 | 4.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
2.0 | 4.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
2.0 | 5.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.0 | 3.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.9 | 5.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.9 | 7.8 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.9 | 3.9 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.9 | 5.7 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
1.9 | 1.9 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
1.9 | 13.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.9 | 5.7 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.9 | 1.9 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
1.9 | 7.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.9 | 1.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.9 | 7.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.9 | 9.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
1.9 | 9.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.9 | 3.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.9 | 13.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.9 | 3.7 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.8 | 5.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.8 | 5.5 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.8 | 7.4 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
1.8 | 1.8 | GO:0043217 | myelin maintenance(GO:0043217) |
1.8 | 7.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.8 | 7.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.8 | 5.4 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.8 | 5.4 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.8 | 1.8 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
1.8 | 5.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.8 | 3.5 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
1.8 | 33.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.8 | 7.0 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
1.7 | 6.9 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.7 | 13.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.7 | 17.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
1.7 | 34.4 | GO:0001964 | startle response(GO:0001964) |
1.7 | 6.8 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.7 | 3.4 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
1.7 | 13.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
1.7 | 5.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.7 | 11.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.7 | 3.3 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
1.7 | 5.0 | GO:0015888 | thiamine transport(GO:0015888) |
1.7 | 19.9 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
1.7 | 1.7 | GO:1901656 | glycoside transport(GO:1901656) |
1.6 | 3.3 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
1.6 | 3.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.6 | 4.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.6 | 6.5 | GO:0003139 | secondary heart field specification(GO:0003139) |
1.6 | 9.7 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
1.6 | 6.5 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.6 | 8.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.6 | 3.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.6 | 82.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.6 | 19.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.6 | 4.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.6 | 1.6 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
1.6 | 1.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.6 | 1.6 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.6 | 3.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.5 | 1.5 | GO:0070384 | Harderian gland development(GO:0070384) |
1.5 | 4.6 | GO:0030421 | defecation(GO:0030421) |
1.5 | 7.7 | GO:0030432 | peristalsis(GO:0030432) |
1.5 | 1.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.5 | 3.1 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
1.5 | 4.6 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.5 | 4.6 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.5 | 4.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.5 | 13.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.5 | 4.5 | GO:0008306 | associative learning(GO:0008306) |
1.5 | 4.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
1.5 | 4.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.5 | 27.9 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
1.5 | 4.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.5 | 2.9 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.5 | 5.8 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
1.5 | 1.5 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
1.4 | 7.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.4 | 1.4 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.4 | 4.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.4 | 4.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.4 | 5.7 | GO:0001927 | exocyst assembly(GO:0001927) |
1.4 | 4.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.4 | 4.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.4 | 1.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.4 | 5.6 | GO:0046102 | inosine metabolic process(GO:0046102) |
1.4 | 4.2 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
1.4 | 4.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.4 | 9.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.4 | 4.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.4 | 4.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.4 | 2.8 | GO:0009629 | response to gravity(GO:0009629) |
1.4 | 4.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.4 | 2.7 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
1.4 | 2.7 | GO:0035425 | autocrine signaling(GO:0035425) |
1.4 | 1.4 | GO:0043366 | beta selection(GO:0043366) |
1.3 | 6.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.3 | 5.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.3 | 6.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.3 | 4.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.3 | 2.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.3 | 3.9 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.3 | 15.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
1.3 | 5.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.3 | 9.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.3 | 26.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.3 | 6.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.3 | 24.0 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
1.3 | 6.3 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.3 | 5.0 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
1.3 | 5.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
1.3 | 12.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.2 | 6.2 | GO:0070842 | aggresome assembly(GO:0070842) |
1.2 | 2.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.2 | 5.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.2 | 3.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.2 | 3.7 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.2 | 1.2 | GO:0035106 | operant conditioning(GO:0035106) |
1.2 | 3.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
1.2 | 2.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.2 | 1.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.2 | 1.2 | GO:0009414 | response to water deprivation(GO:0009414) |
1.2 | 9.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
1.2 | 4.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.2 | 2.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.2 | 3.7 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.2 | 1.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
1.2 | 17.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
1.2 | 3.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.2 | 6.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.2 | 3.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.2 | 1.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
1.2 | 94.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.2 | 3.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.2 | 3.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.2 | 3.6 | GO:0038001 | paracrine signaling(GO:0038001) |
1.2 | 3.5 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
1.2 | 2.4 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.2 | 8.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.2 | 12.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.2 | 4.6 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
1.2 | 9.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
1.2 | 5.8 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.2 | 2.3 | GO:0097503 | sialylation(GO:0097503) |
1.1 | 5.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
1.1 | 10.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.1 | 4.5 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
1.1 | 10.2 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
1.1 | 1.1 | GO:0033206 | meiotic chromosome movement towards spindle pole(GO:0016344) meiotic cytokinesis(GO:0033206) chromosome movement towards spindle pole(GO:0051305) |
1.1 | 3.4 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.1 | 3.4 | GO:1905065 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
1.1 | 6.7 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.1 | 3.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.1 | 1.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
1.1 | 2.2 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.1 | 1.1 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
1.1 | 3.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.1 | 3.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.1 | 1.1 | GO:0090135 | actin filament branching(GO:0090135) |
1.1 | 5.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
1.1 | 4.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
1.1 | 2.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.1 | 1.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.1 | 3.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.1 | 7.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.1 | 10.5 | GO:0031000 | response to caffeine(GO:0031000) |
1.1 | 2.1 | GO:0060618 | nipple development(GO:0060618) |
1.1 | 2.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.1 | 2.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.1 | 9.5 | GO:0021766 | hippocampus development(GO:0021766) |
1.0 | 6.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.0 | 4.2 | GO:0048840 | otolith development(GO:0048840) |
1.0 | 6.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.0 | 3.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.0 | 3.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
1.0 | 4.2 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
1.0 | 2.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.0 | 4.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
1.0 | 3.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
1.0 | 6.2 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
1.0 | 4.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.0 | 9.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
1.0 | 2.0 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
1.0 | 1.0 | GO:0051795 | positive regulation of catagen(GO:0051795) |
1.0 | 4.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.0 | 1.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.0 | 6.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.0 | 1.0 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
1.0 | 1.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
1.0 | 3.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
1.0 | 5.0 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
1.0 | 5.9 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.0 | 6.9 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
1.0 | 2.0 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
1.0 | 3.9 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
1.0 | 4.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.0 | 2.9 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.0 | 1.9 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.0 | 8.7 | GO:0001696 | gastric acid secretion(GO:0001696) |
1.0 | 3.9 | GO:0060179 | male mating behavior(GO:0060179) |
1.0 | 1.9 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
1.0 | 2.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.0 | 1.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
1.0 | 2.9 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.9 | 1.9 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.9 | 2.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.9 | 2.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.9 | 1.9 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.9 | 0.9 | GO:0007567 | parturition(GO:0007567) |
0.9 | 4.7 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.9 | 6.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.9 | 9.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.9 | 8.4 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.9 | 2.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.9 | 4.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.9 | 2.8 | GO:0050955 | thermoception(GO:0050955) |
0.9 | 0.9 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.9 | 1.8 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.9 | 1.8 | GO:0016264 | gap junction assembly(GO:0016264) |
0.9 | 2.7 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.9 | 2.7 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.9 | 2.7 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.9 | 3.6 | GO:0071435 | potassium ion export(GO:0071435) |
0.9 | 2.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.9 | 5.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.9 | 6.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.9 | 2.7 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.9 | 13.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.9 | 1.8 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.9 | 2.7 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.9 | 2.7 | GO:0070141 | response to UV-A(GO:0070141) |
0.9 | 1.8 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.9 | 2.7 | GO:0042637 | catagen(GO:0042637) |
0.9 | 2.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.9 | 2.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.9 | 3.5 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.9 | 8.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.9 | 2.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.9 | 2.6 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.9 | 1.7 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.9 | 1.7 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.9 | 1.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.9 | 1.7 | GO:0051182 | coenzyme transport(GO:0051182) |
0.9 | 1.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.9 | 4.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.9 | 3.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.9 | 0.9 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.8 | 7.6 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.8 | 2.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.8 | 3.4 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.8 | 3.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.8 | 2.5 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.8 | 7.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.8 | 0.8 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.8 | 0.8 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.8 | 14.1 | GO:0007616 | long-term memory(GO:0007616) |
0.8 | 2.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.8 | 0.8 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.8 | 1.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.8 | 6.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.8 | 2.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.8 | 2.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.8 | 5.7 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.8 | 9.0 | GO:0036065 | fucosylation(GO:0036065) |
0.8 | 0.8 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.8 | 2.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.8 | 1.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.8 | 1.6 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.8 | 3.2 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.8 | 0.8 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.8 | 2.4 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.8 | 2.4 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.8 | 0.8 | GO:0007412 | axon target recognition(GO:0007412) |
0.8 | 1.6 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.8 | 1.6 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.8 | 2.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.8 | 9.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.8 | 3.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.8 | 0.8 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.8 | 1.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.8 | 5.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.8 | 1.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.8 | 0.8 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.8 | 0.8 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.8 | 1.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.8 | 3.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.8 | 1.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.8 | 2.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.8 | 2.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.8 | 3.9 | GO:0043084 | penile erection(GO:0043084) |
0.8 | 1.5 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.8 | 0.8 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.8 | 3.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.8 | 5.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.8 | 1.5 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.8 | 1.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.8 | 6.9 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.8 | 6.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.8 | 4.5 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.8 | 1.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.8 | 1.5 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.8 | 5.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.8 | 0.8 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.8 | 5.3 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.8 | 15.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.8 | 1.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.8 | 1.5 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.7 | 23.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.7 | 3.0 | GO:1902287 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.7 | 2.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.7 | 6.7 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.7 | 3.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.7 | 3.0 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.7 | 19.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.7 | 4.4 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.7 | 38.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.7 | 1.5 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.7 | 2.9 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.7 | 2.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.7 | 0.7 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.7 | 3.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.7 | 2.2 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.7 | 3.6 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.7 | 5.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.7 | 0.7 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.7 | 11.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.7 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.7 | 1.4 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.7 | 2.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 1.4 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.7 | 2.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.7 | 7.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.7 | 2.8 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.7 | 2.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.7 | 12.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.7 | 0.7 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.7 | 1.4 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.7 | 3.5 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.7 | 2.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.7 | 3.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.7 | 2.8 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.7 | 3.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 1.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.7 | 1.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.7 | 2.8 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.7 | 2.7 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.7 | 2.7 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.7 | 1.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.7 | 2.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.7 | 14.8 | GO:0008542 | visual learning(GO:0008542) |
0.7 | 6.0 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.7 | 1.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.7 | 2.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.7 | 2.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.7 | 2.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.7 | 4.0 | GO:0015824 | proline transport(GO:0015824) |
0.7 | 1.3 | GO:0042220 | response to cocaine(GO:0042220) |
0.7 | 2.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.7 | 2.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.7 | 2.6 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.7 | 0.7 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.7 | 2.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.7 | 3.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.7 | 1.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.7 | 2.0 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.7 | 2.0 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.6 | 1.9 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.6 | 3.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.6 | 3.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.6 | 1.3 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.6 | 2.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.6 | 4.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.6 | 2.5 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.6 | 1.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.6 | 1.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.6 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.6 | 1.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.6 | 2.5 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.6 | 2.5 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.6 | 1.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.6 | 3.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.6 | 3.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.6 | 1.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.6 | 4.9 | GO:0009209 | pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
0.6 | 1.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.6 | 3.7 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.6 | 6.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.6 | 1.8 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.6 | 3.0 | GO:0015884 | folic acid transport(GO:0015884) |
0.6 | 3.0 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.6 | 1.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 0.6 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.6 | 8.9 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.6 | 1.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.6 | 2.4 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.6 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.6 | 13.1 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.6 | 1.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.6 | 13.5 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.6 | 1.8 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.6 | 0.6 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 0.6 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.6 | 1.7 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.6 | 0.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.6 | 1.2 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.6 | 2.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.6 | 1.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.6 | 0.6 | GO:0031649 | heat generation(GO:0031649) |
0.6 | 2.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.6 | 4.0 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.6 | 1.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.6 | 8.0 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.6 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.6 | 14.7 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.6 | 2.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.6 | 31.1 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.6 | 4.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.6 | 0.6 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.6 | 5.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.6 | 6.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.6 | 1.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.6 | 2.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.6 | 2.8 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.6 | 0.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.6 | 2.2 | GO:0035640 | exploration behavior(GO:0035640) |
0.6 | 1.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.6 | 0.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.6 | 1.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.6 | 1.1 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.6 | 1.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.6 | 3.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.5 | 0.5 | GO:0090148 | membrane fission(GO:0090148) |
0.5 | 2.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.5 | 3.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.5 | 1.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.5 | 3.8 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.5 | 1.6 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.5 | 1.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.5 | 2.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.5 | 0.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.5 | 2.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.5 | 1.6 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.5 | 1.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 1.0 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.5 | 3.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.5 | 4.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.5 | 2.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.5 | 0.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.5 | 1.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.5 | 1.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.5 | 2.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.5 | 1.5 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.5 | 2.0 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.5 | 3.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.5 | 11.2 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.5 | 2.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.5 | 1.0 | GO:0001757 | somite specification(GO:0001757) |
0.5 | 1.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.5 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 1.0 | GO:0060022 | hard palate development(GO:0060022) |
0.5 | 0.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.5 | 1.0 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.5 | 0.5 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.5 | 1.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 0.5 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.5 | 3.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.5 | 2.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 1.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.5 | 0.5 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.5 | 1.0 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.5 | 1.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.5 | 1.5 | GO:1901070 | GMP biosynthetic process(GO:0006177) guanosine-containing compound biosynthetic process(GO:1901070) |
0.5 | 2.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.5 | 1.9 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.5 | 1.9 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 1.5 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.5 | 1.0 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.5 | 2.9 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.5 | 1.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.5 | 1.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.5 | 1.0 | GO:0097421 | liver regeneration(GO:0097421) |
0.5 | 1.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.5 | 1.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 1.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.5 | 1.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.5 | 8.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.5 | 10.0 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.5 | 1.0 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.5 | 1.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.5 | 0.9 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.5 | 1.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.5 | 0.9 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.5 | 1.4 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 0.9 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.5 | 0.5 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.5 | 0.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.5 | 0.5 | GO:0015755 | fructose transport(GO:0015755) |
0.5 | 1.9 | GO:0042756 | drinking behavior(GO:0042756) |
0.5 | 1.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 23.2 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.5 | 12.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.5 | 1.4 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
0.5 | 2.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.5 | 0.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 0.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.5 | 1.4 | GO:0046909 | intermembrane transport(GO:0046909) |
0.5 | 0.9 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.5 | 1.4 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.5 | 2.7 | GO:0060074 | synapse maturation(GO:0060074) |
0.5 | 0.5 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.5 | 0.9 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.5 | 1.8 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.4 | 1.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 3.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.4 | 1.3 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.4 | 2.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.4 | 0.9 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.4 | 0.9 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.4 | 2.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.4 | 1.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.4 | 2.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 6.1 | GO:0014044 | Schwann cell development(GO:0014044) |
0.4 | 1.7 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 1.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.4 | 0.4 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
0.4 | 1.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 1.3 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.4 | 2.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.4 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.4 | 4.3 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.4 | 1.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 5.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
0.4 | 3.0 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.4 | 1.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.4 | 0.4 | GO:0007632 | visual behavior(GO:0007632) |
0.4 | 1.7 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.4 | 0.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.4 | 1.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.4 | 4.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 0.4 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.4 | 1.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 0.4 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 2.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.4 | 1.2 | GO:0015867 | ATP transport(GO:0015867) |
0.4 | 10.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.4 | 0.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.4 | 0.8 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.4 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 1.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 0.8 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.4 | 2.8 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.4 | 9.5 | GO:0060612 | adipose tissue development(GO:0060612) |
0.4 | 0.4 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.4 | 5.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.4 | 2.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.4 | 1.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 5.5 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.4 | 4.7 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.4 | 2.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.4 | 0.4 | GO:0002339 | B cell selection(GO:0002339) |
0.4 | 1.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.4 | 0.4 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.4 | 0.4 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.4 | 1.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 0.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.4 | 0.4 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.4 | 3.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.4 | 1.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 0.8 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.4 | 4.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.4 | 0.8 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 1.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.4 | 0.8 | GO:0032095 | regulation of response to food(GO:0032095) |
0.4 | 0.8 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.4 | 1.5 | GO:0035627 | ceramide transport(GO:0035627) |
0.4 | 4.9 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.4 | 0.4 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.4 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 0.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.4 | 1.1 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.4 | 1.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.4 | 1.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.4 | 1.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.4 | 0.7 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 3.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.4 | 0.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.4 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.4 | 1.5 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.4 | 1.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 1.1 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 0.7 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.4 | 2.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.4 | 3.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.4 | 2.1 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 0.4 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.4 | 2.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.4 | 2.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 3.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 2.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 4.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 1.0 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 5.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 1.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.3 | 19.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 0.7 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 0.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.3 | 0.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.3 | 0.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 0.3 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.3 | 1.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 1.0 | GO:0048678 | response to axon injury(GO:0048678) |
0.3 | 2.4 | GO:0009301 | snRNA transcription(GO:0009301) |
0.3 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 1.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.3 | 1.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 0.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.7 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.3 | 0.3 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.3 | 1.0 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.3 | 1.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.3 | 1.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 1.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.3 | 1.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 1.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 1.0 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.3 | 0.3 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.3 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 0.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 1.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 1.0 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 1.0 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.3 | 6.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.3 | 1.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 1.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 0.7 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.3 | 2.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 0.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.3 | 4.9 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 1.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 0.7 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.3 | 1.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.3 | 0.6 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
0.3 | 1.9 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 4.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.3 | 1.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 1.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 1.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 0.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.3 | 0.6 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.3 | 0.9 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 2.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 0.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 1.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 1.9 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.3 | 0.3 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 0.9 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 0.6 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 0.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.3 | 0.9 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.3 | 2.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.3 | 0.9 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 0.3 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.3 | 1.5 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.6 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 4.8 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 1.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 3.0 | GO:0016358 | dendrite development(GO:0016358) |
0.3 | 3.6 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.3 | 0.9 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.3 | 0.6 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.3 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 1.5 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.3 | 1.5 | GO:0060004 | reflex(GO:0060004) |
0.3 | 0.6 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.3 | 4.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.3 | 1.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.3 | 3.2 | GO:0009268 | response to pH(GO:0009268) |
0.3 | 0.9 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.3 | 3.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 2.0 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.3 | 0.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.3 | 1.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.3 | 0.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 0.3 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.3 | 0.9 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.3 | 0.9 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.3 | 0.6 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.3 | 5.2 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.3 | 1.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 6.6 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.3 | 1.4 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.3 | 3.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.3 | 0.8 | GO:0014910 | regulation of smooth muscle cell migration(GO:0014910) |
0.3 | 1.1 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.3 | 0.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.3 | 3.6 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.3 | 0.6 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.3 | 1.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.3 | 0.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 0.3 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.3 | 0.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 1.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 1.4 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.3 | 0.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 1.4 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.3 | 0.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 1.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.3 | 1.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.8 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.3 | 2.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 1.3 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.3 | 0.8 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.3 | 0.8 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 0.8 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.3 | 1.6 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.3 | 2.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.3 | 0.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 0.5 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 0.5 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.3 | 0.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 0.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 1.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.3 | 6.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.3 | 5.7 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.3 | 0.3 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.3 | 11.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 1.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 0.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.3 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 0.5 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 0.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.3 | 1.0 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.3 | 1.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.3 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.2 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.2 | 0.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.2 | 2.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.5 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.2 | 0.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.2 | 0.2 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.2 | 2.7 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.2 | 0.2 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 3.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 4.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.5 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.2 | 2.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 2.4 | GO:0014904 | myotube cell development(GO:0014904) |
0.2 | 0.5 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 6.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.2 | 0.5 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.2 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.2 | 0.2 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 1.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 1.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.7 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 5.0 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.2 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.2 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.2 | 0.9 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 1.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.7 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.5 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.7 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.2 | 1.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 2.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.9 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.2 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.5 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 3.4 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.2 | 1.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.7 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.4 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 0.4 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 2.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.2 | 1.9 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 0.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 2.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 1.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 1.9 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 0.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 1.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.6 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.2 | 0.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 3.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.6 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 2.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.2 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.2 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.2 | 0.6 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.2 | 0.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 3.0 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.4 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.2 | 1.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 0.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.4 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.2 | 1.6 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.2 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 2.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 1.0 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 0.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 0.4 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.2 | 0.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.6 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.2 | 0.2 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.8 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.2 | 0.6 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.6 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 1.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.2 | 0.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 1.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.2 | 0.4 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.2 | 0.9 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.2 | 0.7 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.2 | 2.1 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.2 | 0.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.2 | 0.2 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.2 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.5 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 0.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.5 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.2 | 0.4 | GO:0010042 | response to manganese ion(GO:0010042) |
0.2 | 1.4 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.2 | 2.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 1.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.2 | 0.9 | GO:0007622 | rhythmic behavior(GO:0007622) |
0.2 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 1.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 1.1 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.2 | 0.5 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.2 | 1.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.2 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.2 | 0.4 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 2.9 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.2 | 0.3 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 1.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 0.3 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.2 | 0.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.7 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.2 | 1.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 9.8 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.2 | 0.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 1.3 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.2 | 0.3 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.2 | 0.5 | GO:0010975 | regulation of neuron projection development(GO:0010975) |
0.2 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.5 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 1.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.8 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.2 | 0.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 2.6 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 1.3 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.2 | 1.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 1.6 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.2 | 1.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 1.0 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 1.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.5 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 2.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.6 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.2 | 0.5 | GO:0010659 | cardiac muscle cell apoptotic process(GO:0010659) |
0.2 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.6 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.2 | 0.3 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.2 | 0.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 1.8 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.5 | GO:0002063 | chondrocyte development(GO:0002063) |
0.2 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.2 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.7 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 1.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.4 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.1 | GO:0003129 | heart induction(GO:0003129) |
0.1 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 4.2 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.1 | GO:0018214 | protein carboxylation(GO:0018214) |
0.1 | 0.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 1.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.6 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.6 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.1 | 0.4 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.1 | 0.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 1.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.4 | GO:1903206 | negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.1 | 0.3 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.7 | GO:0031279 | regulation of cyclase activity(GO:0031279) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 1.0 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.7 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.1 | 0.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.1 | 21.3 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 1.8 | GO:0050804 | modulation of synaptic transmission(GO:0050804) |
0.1 | 0.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.4 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.5 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 0.6 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.1 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 1.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.7 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 1.0 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.1 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.1 | 0.4 | GO:0070570 | regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.5 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.2 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.8 | GO:1903405 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 1.0 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 1.0 | GO:0001508 | action potential(GO:0001508) |
0.1 | 1.6 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.1 | 0.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 0.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 1.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.2 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 1.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.3 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 3.0 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.1 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.1 | 0.6 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.8 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 3.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.1 | 1.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 2.1 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.5 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.3 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 2.1 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.4 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 1.7 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.3 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.5 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 1.6 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.1 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.2 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.1 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.4 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.8 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.1 | 0.2 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 1.3 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.9 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.5 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.9 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.1 | GO:0071605 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.1 | 0.1 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
0.1 | 0.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 0.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.1 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 2.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.8 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.4 | GO:0010573 | vascular endothelial growth factor production(GO:0010573) |
0.1 | 15.8 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 1.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.4 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.1 | GO:0060306 | regulation of membrane repolarization(GO:0060306) |
0.1 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.3 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.1 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.1 | 0.6 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.1 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 0.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0060399 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.3 | GO:0015844 | monoamine transport(GO:0015844) |
0.1 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.1 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.1 | 0.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.0 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.0 | 0.0 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.0 | 0.0 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.0 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.2 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.0 | 0.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.0 | 0.0 | GO:0097205 | renal filtration(GO:0097205) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.0 | 0.0 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.0 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.0 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.0 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.4 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.0 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.0 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 1.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.0 | 0.8 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.0 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.0 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.0 | GO:0042148 | strand invasion(GO:0042148) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.0 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.0 | 0.0 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.0 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.0 | 0.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.0 | 0.0 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 1.0 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 1.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0043144 | snoRNA processing(GO:0043144) |
0.0 | 0.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.0 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.1 | GO:0042407 | cristae formation(GO:0042407) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 15.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
3.6 | 10.7 | GO:1990635 | proximal dendrite(GO:1990635) |
3.5 | 10.5 | GO:0072534 | perineuronal net(GO:0072534) |
3.5 | 17.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
3.4 | 40.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
3.4 | 13.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
3.2 | 38.4 | GO:0043194 | axon initial segment(GO:0043194) |
3.1 | 12.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.6 | 23.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.5 | 71.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
2.4 | 34.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
2.4 | 7.2 | GO:0032280 | symmetric synapse(GO:0032280) |
2.2 | 15.3 | GO:0032584 | growth cone membrane(GO:0032584) |
2.1 | 31.9 | GO:0031045 | dense core granule(GO:0031045) |
1.8 | 3.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.8 | 5.3 | GO:0097443 | sorting endosome(GO:0097443) |
1.7 | 6.9 | GO:0044308 | axonal spine(GO:0044308) |
1.7 | 65.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.7 | 5.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.6 | 22.6 | GO:0031430 | M band(GO:0031430) |
1.6 | 4.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.6 | 3.2 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
1.6 | 7.9 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.6 | 7.8 | GO:0060076 | excitatory synapse(GO:0060076) |
1.5 | 9.2 | GO:0043083 | synaptic cleft(GO:0043083) |
1.5 | 1.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.5 | 7.3 | GO:0000235 | astral microtubule(GO:0000235) |
1.4 | 36.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.4 | 25.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.4 | 4.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.4 | 5.6 | GO:0042583 | chromaffin granule(GO:0042583) |
1.3 | 6.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.3 | 29.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.3 | 12.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.3 | 4.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.3 | 71.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.3 | 21.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.3 | 6.5 | GO:0033268 | node of Ranvier(GO:0033268) |
1.3 | 9.0 | GO:0030673 | axolemma(GO:0030673) |
1.2 | 3.7 | GO:1990393 | 3M complex(GO:1990393) |
1.2 | 2.5 | GO:0034705 | potassium channel complex(GO:0034705) |
1.2 | 18.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.2 | 1.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.2 | 28.0 | GO:0044295 | axonal growth cone(GO:0044295) |
1.2 | 3.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.2 | 3.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.2 | 2.3 | GO:0034706 | sodium channel complex(GO:0034706) |
1.2 | 15.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.2 | 2.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.1 | 2.3 | GO:0071203 | WASH complex(GO:0071203) |
1.1 | 1.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.1 | 145.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.1 | 10.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.1 | 1.1 | GO:0005883 | neurofilament(GO:0005883) |
1.1 | 3.2 | GO:0043511 | inhibin complex(GO:0043511) |
1.1 | 2.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.0 | 8.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.0 | 10.2 | GO:0032433 | filopodium tip(GO:0032433) |
1.0 | 1.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.0 | 88.0 | GO:0043204 | perikaryon(GO:0043204) |
0.9 | 2.8 | GO:0044393 | microspike(GO:0044393) |
0.9 | 12.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.9 | 4.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.9 | 8.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.9 | 2.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.9 | 0.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.9 | 1.8 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.9 | 3.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.9 | 6.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.8 | 3.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.8 | 7.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.8 | 0.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.8 | 4.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.8 | 1.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 2.5 | GO:0031417 | NatC complex(GO:0031417) |
0.8 | 3.3 | GO:0030478 | actin cap(GO:0030478) |
0.8 | 5.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.8 | 4.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.8 | 24.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.8 | 1.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 5.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.8 | 1.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.8 | 0.8 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.8 | 4.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.8 | 3.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.8 | 6.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.8 | 1.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.8 | 0.8 | GO:0044298 | cell body membrane(GO:0044298) |
0.8 | 3.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.8 | 3.8 | GO:0097433 | dense body(GO:0097433) |
0.8 | 10.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.8 | 0.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.8 | 6.1 | GO:0034464 | BBSome(GO:0034464) |
0.8 | 1.5 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.7 | 101.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.7 | 4.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 7.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.7 | 2.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.7 | 2.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.7 | 2.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.7 | 54.8 | GO:0043679 | axon terminus(GO:0043679) |
0.7 | 1.4 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.7 | 3.4 | GO:0043203 | axon hillock(GO:0043203) |
0.7 | 2.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.7 | 2.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.7 | 0.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.7 | 5.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.7 | 1.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.7 | 3.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.6 | 35.8 | GO:0030426 | growth cone(GO:0030426) |
0.6 | 1.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 2.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.6 | 7.9 | GO:0043205 | fibril(GO:0043205) |
0.6 | 1.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.6 | 7.9 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.6 | 58.7 | GO:0098794 | postsynapse(GO:0098794) |
0.6 | 42.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.6 | 4.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.6 | 4.8 | GO:0060091 | kinocilium(GO:0060091) |
0.6 | 7.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 1.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.6 | 3.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.6 | 1.2 | GO:0097546 | ciliary base(GO:0097546) |
0.6 | 2.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.6 | 3.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.6 | 3.5 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.6 | 1.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.6 | 1.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.5 | 2.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.5 | 1.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 8.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 2.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.5 | 1.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.5 | 0.5 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.5 | 1.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 1.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 0.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 0.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 6.6 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.5 | 1.5 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 2.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.5 | 1.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.5 | 3.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 2.5 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 118.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.5 | 2.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 3.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.5 | 1.9 | GO:0032021 | NELF complex(GO:0032021) |
0.5 | 2.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.5 | 2.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 5.6 | GO:0036038 | MKS complex(GO:0036038) |
0.5 | 10.0 | GO:0030315 | T-tubule(GO:0030315) |
0.4 | 2.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 8.1 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.4 | 2.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 1.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 20.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.4 | 3.6 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.4 | 0.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 2.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 1.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.4 | 1.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.4 | 4.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.4 | 1.7 | GO:0035363 | histone locus body(GO:0035363) |
0.4 | 3.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.4 | 7.6 | GO:0060170 | ciliary membrane(GO:0060170) |
0.4 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 4.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 7.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.4 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.4 | 2.5 | GO:0002102 | podosome(GO:0002102) |
0.4 | 2.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 19.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 26.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.4 | 3.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 4.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 34.9 | GO:0045202 | synapse(GO:0045202) |
0.4 | 5.7 | GO:0072372 | primary cilium(GO:0072372) |
0.4 | 0.8 | GO:0005652 | nuclear lamina(GO:0005652) |
0.4 | 11.5 | GO:0005921 | gap junction(GO:0005921) |
0.4 | 2.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 1.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 6.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 5.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.4 | 1.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.4 | 1.5 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.4 | 1.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 1.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 0.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.4 | 1.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.4 | 1.4 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 1.4 | GO:0002177 | manchette(GO:0002177) |
0.4 | 2.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.4 | 2.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 1.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.4 | 129.7 | GO:0043005 | neuron projection(GO:0043005) |
0.4 | 11.9 | GO:0016459 | myosin complex(GO:0016459) |
0.3 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 2.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 3.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 1.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.3 | 4.1 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 1.0 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 8.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 29.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.3 | 2.5 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.3 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 1.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 2.2 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 2.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 6.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 16.1 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.3 | 4.4 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.3 | 1.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 29.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.3 | 8.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.3 | 2.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 3.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 1.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.3 | 0.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.3 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 15.4 | GO:0043025 | neuronal cell body(GO:0043025) |
0.3 | 14.0 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.3 | 0.8 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 0.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 10.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 1.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 1.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 1.3 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 4.8 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.2 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 2.7 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.2 | 1.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.2 | 3.6 | GO:0030133 | transport vesicle(GO:0030133) |
0.2 | 23.7 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 6.5 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 1.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 0.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 2.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 1.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 1.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 1.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 2.0 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 8.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 3.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 10.6 | GO:0097458 | neuron part(GO:0097458) |
0.2 | 1.1 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 0.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 1.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 1.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 4.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 2.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.6 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 4.6 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.2 | 0.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.2 | 4.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 2.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 9.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 0.2 | GO:0098803 | respiratory chain complex(GO:0098803) |
0.2 | 0.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.1 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 0.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 3.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 2.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 0.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 11.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 0.8 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 2.2 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 1.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 1.1 | GO:0070187 | telosome(GO:0070187) |
0.1 | 1.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 6.0 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 9.5 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 96.1 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 0.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 85.7 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 2.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.8 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 2.9 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 4.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.1 | GO:0031672 | A band(GO:0031672) |
0.1 | 1.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 2.4 | GO:0031253 | cell projection membrane(GO:0031253) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 329.4 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.1 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 1.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 2.0 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.7 | GO:0098552 | side of membrane(GO:0098552) |
0.1 | 2.4 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.1 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 2.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.3 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.1 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 1.2 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 10.0 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.1 | 1.0 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 4.4 | GO:0005929 | cilium(GO:0005929) |
0.1 | 0.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.9 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 2.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 1.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 33.9 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.0 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.3 | GO:0016592 | mediator complex(GO:0016592) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.4 | 33.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
8.3 | 41.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
5.0 | 20.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
4.5 | 13.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
4.4 | 17.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
4.3 | 13.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
4.2 | 8.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
4.0 | 20.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
4.0 | 11.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
3.9 | 11.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
3.6 | 3.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
3.6 | 43.1 | GO:0016595 | glutamate binding(GO:0016595) |
3.4 | 10.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.3 | 16.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.3 | 9.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
3.3 | 9.8 | GO:0035939 | microsatellite binding(GO:0035939) |
3.1 | 9.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
3.1 | 9.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
3.1 | 12.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
3.0 | 26.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.9 | 8.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.8 | 14.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
2.7 | 8.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.7 | 21.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.7 | 21.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.6 | 7.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.5 | 7.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
2.5 | 12.3 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
2.5 | 7.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.3 | 11.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.3 | 9.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.2 | 11.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.2 | 6.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
2.1 | 2.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.1 | 6.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
2.1 | 23.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
2.0 | 8.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.0 | 4.0 | GO:0043398 | HLH domain binding(GO:0043398) |
2.0 | 7.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.0 | 11.7 | GO:0048495 | Roundabout binding(GO:0048495) |
1.9 | 3.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.9 | 9.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.9 | 7.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.9 | 20.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.9 | 33.9 | GO:0005112 | Notch binding(GO:0005112) |
1.9 | 9.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.9 | 5.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.8 | 5.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.8 | 41.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.8 | 1.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.8 | 14.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.7 | 5.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.7 | 18.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.7 | 23.7 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.7 | 13.3 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.7 | 5.0 | GO:0018574 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
1.6 | 4.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.6 | 6.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.6 | 6.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.6 | 4.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.6 | 1.6 | GO:0005221 | intracellular ligand-gated ion channel activity(GO:0005217) intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
1.6 | 30.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.6 | 7.9 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.6 | 58.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.6 | 3.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.5 | 4.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.5 | 3.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.5 | 3.0 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.4 | 4.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.4 | 14.2 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
1.4 | 7.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.4 | 2.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.4 | 6.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.4 | 4.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.3 | 37.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.3 | 17.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.3 | 2.6 | GO:0051380 | norepinephrine binding(GO:0051380) |
1.3 | 15.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.3 | 9.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.3 | 6.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.3 | 5.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.2 | 2.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.2 | 27.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
1.2 | 3.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.2 | 24.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.2 | 3.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.2 | 10.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.2 | 11.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.2 | 5.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.2 | 5.8 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.2 | 2.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.2 | 2.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.1 | 4.6 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
1.1 | 2.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.1 | 3.4 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.1 | 12.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.1 | 3.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.1 | 4.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.1 | 6.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.1 | 29.3 | GO:0005272 | sodium channel activity(GO:0005272) |
1.1 | 1.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
1.1 | 7.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.1 | 4.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.1 | 3.2 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.1 | 4.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.1 | 19.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.1 | 31.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
1.0 | 4.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.0 | 5.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.0 | 3.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.0 | 7.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.0 | 2.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.0 | 18.5 | GO:0031489 | myosin V binding(GO:0031489) |
1.0 | 13.4 | GO:0015026 | coreceptor activity(GO:0015026) |
1.0 | 40.5 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
1.0 | 20.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.0 | 2.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.0 | 10.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.0 | 42.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
1.0 | 3.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.0 | 3.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
1.0 | 3.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.0 | 6.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
1.0 | 13.4 | GO:0030553 | cGMP binding(GO:0030553) |
1.0 | 11.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.0 | 4.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.9 | 13.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.9 | 2.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.9 | 2.8 | GO:0089720 | caspase binding(GO:0089720) |
0.9 | 28.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.9 | 3.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.9 | 2.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.9 | 4.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.9 | 3.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.9 | 3.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.9 | 11.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.9 | 1.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.9 | 5.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.9 | 0.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.9 | 2.6 | GO:2001070 | starch binding(GO:2001070) |
0.9 | 11.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.9 | 2.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.9 | 7.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.9 | 3.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.9 | 2.6 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.9 | 5.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.9 | 5.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.9 | 1.7 | GO:0005119 | smoothened binding(GO:0005119) |
0.9 | 1.7 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.9 | 2.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.8 | 6.8 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.8 | 21.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.8 | 4.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.8 | 20.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.8 | 12.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.8 | 2.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.8 | 4.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.8 | 0.8 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.8 | 3.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.8 | 2.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.8 | 46.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.8 | 1.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.8 | 2.4 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.8 | 7.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.8 | 23.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.8 | 3.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.8 | 3.9 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.8 | 3.9 | GO:0052758 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.8 | 3.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.8 | 3.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.8 | 5.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.8 | 3.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.8 | 8.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.8 | 1.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.8 | 6.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.8 | 3.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.8 | 4.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.8 | 1.5 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.7 | 2.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.7 | 3.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.7 | 1.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.7 | 5.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.7 | 2.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.7 | 9.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.7 | 5.9 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.7 | 14.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.7 | 3.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.7 | 2.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.7 | 3.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.7 | 0.7 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.7 | 2.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.7 | 8.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.7 | 3.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.7 | 5.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.7 | 2.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.7 | 2.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.7 | 9.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.7 | 1.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.7 | 7.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.7 | 4.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.7 | 4.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 3.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.7 | 2.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.7 | 0.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.7 | 2.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.7 | 3.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.7 | 5.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.7 | 2.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.7 | 2.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.7 | 2.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.7 | 6.5 | GO:0008061 | chitin binding(GO:0008061) |
0.7 | 2.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.7 | 15.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.6 | 16.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.6 | 5.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 2.6 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.6 | 16.0 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.6 | 2.6 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.6 | 2.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.6 | 13.4 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.6 | 1.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.6 | 1.9 | GO:0070061 | fructose binding(GO:0070061) |
0.6 | 1.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 3.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.6 | 4.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.6 | 2.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.6 | 4.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.6 | 3.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.6 | 3.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.6 | 0.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.6 | 1.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.6 | 5.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.6 | 2.4 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.6 | 7.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.6 | 5.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.6 | 8.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.6 | 2.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 4.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.6 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.6 | 1.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.6 | 56.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.6 | 9.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.6 | 2.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.6 | 30.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.6 | 1.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.6 | 3.9 | GO:0031402 | sodium ion binding(GO:0031402) |
0.6 | 4.4 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 6.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.6 | 2.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.6 | 5.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.5 | 4.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.5 | 1.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.5 | 4.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 3.2 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.5 | 1.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 5.2 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.5 | 2.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 5.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.5 | 5.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.5 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.5 | 2.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.5 | 2.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.5 | 1.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 19.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.5 | 4.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 4.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.5 | 1.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.5 | 11.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.5 | 0.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.5 | 1.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 1.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 4.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.5 | 1.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 1.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 4.9 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 1.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.5 | 2.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.5 | 1.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.5 | 6.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 1.9 | GO:0097001 | ceramide binding(GO:0097001) |
0.5 | 1.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.5 | 1.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.5 | 1.4 | GO:0043918 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.5 | 3.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 5.2 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.5 | 5.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 4.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 4.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 0.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 2.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 10.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.5 | 16.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.5 | 1.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 1.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.5 | 2.7 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 7.6 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 1.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.4 | 3.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.4 | 3.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.4 | 6.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.4 | 1.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.4 | 3.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 1.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.4 | 2.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 0.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 2.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.4 | 10.8 | GO:0019838 | growth factor binding(GO:0019838) |
0.4 | 16.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.4 | 4.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 1.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 2.6 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.4 | 1.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 6.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 10.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.4 | 1.7 | GO:0016775 | protein histidine kinase activity(GO:0004673) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.4 | 12.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.4 | 1.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 0.8 | GO:0009374 | biotin binding(GO:0009374) |
0.4 | 1.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 0.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 21.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 5.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 9.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 13.7 | GO:0017022 | myosin binding(GO:0017022) |
0.4 | 2.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.4 | 0.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.4 | 1.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.4 | 1.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 3.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 4.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.4 | 5.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.4 | 1.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 1.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 30.8 | GO:0008201 | heparin binding(GO:0008201) |
0.4 | 0.8 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 5.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.4 | 0.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.4 | 0.7 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 1.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.4 | 6.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 1.1 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.4 | 0.7 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 0.7 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 1.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 0.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 4.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 4.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 0.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 2.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 0.3 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.3 | 1.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 3.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 1.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 10.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.3 | 1.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 3.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 12.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 1.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 15.8 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.3 | 3.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 1.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.3 | 4.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.3 | 1.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 2.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 2.9 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.3 | 4.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 2.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 1.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 0.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 6.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 4.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 4.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 0.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 3.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 1.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 3.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 0.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 0.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 2.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 0.9 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.3 | 2.1 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.3 | 0.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 2.3 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.3 | 4.7 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.3 | 2.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 2.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 1.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 2.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 1.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.3 | 3.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 3.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 0.3 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) |
0.3 | 1.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 1.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 1.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 0.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 1.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 1.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 70.7 | GO:0032561 | guanyl ribonucleotide binding(GO:0032561) |
0.3 | 1.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.3 | 2.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 1.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 1.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 0.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.3 | 0.3 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.3 | 1.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.3 | 5.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.3 | 1.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.3 | 1.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 2.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 0.5 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 2.8 | GO:0044654 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.3 | 3.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 1.5 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 1.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 1.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 1.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 0.7 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.7 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.5 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 1.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 3.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 0.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.7 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.2 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 4.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 5.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 1.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.6 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 3.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 0.8 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 1.4 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 1.6 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.2 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.2 | 14.6 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 1.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 0.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 1.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 1.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 3.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 0.6 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.2 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.2 | 0.2 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.2 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 0.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 2.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 1.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.2 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 0.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 0.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.9 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 13.9 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 1.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 0.5 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 1.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 2.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 1.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 0.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 2.0 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.2 | 54.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 0.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.2 | 0.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 3.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 2.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 1.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 14.0 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.2 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 1.5 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.2 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 3.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 3.4 | GO:0015297 | antiporter activity(GO:0015297) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 2.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.6 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 1.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 11.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 24.4 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 1.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.4 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.1 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.9 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.5 | GO:0018855 | acyl-CoA ligase activity(GO:0003996) succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.5 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 6.4 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 2.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.9 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 1.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.2 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.7 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 3.8 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 1.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.3 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 1.8 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 1.4 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 3.6 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 0.1 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.1 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.5 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 1.3 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.2 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.9 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 4.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.3 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 1.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 1.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.3 | GO:0015085 | calcium ion transmembrane transporter activity(GO:0015085) |
0.1 | 0.1 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 2.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 4.0 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.6 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 5.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 2.9 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 1.2 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.7 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.1 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.2 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.0 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.5 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 1.0 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 1.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.1 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 1.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.0 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.7 | 1.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.5 | 90.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.5 | 31.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.5 | 20.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.5 | 20.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.4 | 23.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.3 | 45.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.2 | 26.5 | PID REELIN PATHWAY | Reelin signaling pathway |
1.0 | 23.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.0 | 14.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.9 | 160.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.9 | 21.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.9 | 7.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.9 | 7.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.9 | 0.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.8 | 11.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.7 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.7 | 12.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 16.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.7 | 10.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.7 | 1.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.7 | 9.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.7 | 31.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.7 | 2.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.7 | 2.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 0.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.7 | 10.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.6 | 12.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.6 | 5.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.6 | 2.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 2.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.5 | 73.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 10.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 4.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 12.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 9.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 2.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 1.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 1.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.4 | 10.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 2.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 1.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 21.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.4 | 4.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 14.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 3.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 81.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 64.6 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.3 | 4.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 0.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.3 | 2.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 2.6 | PID FGF PATHWAY | FGF signaling pathway |
0.3 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 2.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 1.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 4.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 2.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 1.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 4.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 2.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 4.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 5.8 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 1.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 5.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 2.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 2.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 3.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 3.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 1.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 2.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 1.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 3.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.7 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 1.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 28.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
3.0 | 24.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.9 | 43.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.8 | 16.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
2.4 | 28.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
2.3 | 2.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
2.1 | 21.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
2.1 | 23.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
2.1 | 4.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
2.0 | 50.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.9 | 20.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.8 | 19.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.6 | 37.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.6 | 19.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.6 | 22.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.6 | 25.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
1.6 | 15.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.5 | 20.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.5 | 4.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.3 | 11.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.3 | 26.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.3 | 23.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
1.2 | 12.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.2 | 21.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.2 | 14.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
1.2 | 1.2 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
1.2 | 22.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.1 | 25.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.1 | 45.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.1 | 19.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.1 | 39.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.1 | 1.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
1.0 | 1.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.0 | 3.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.0 | 9.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.0 | 8.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.0 | 17.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.9 | 8.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.9 | 30.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.8 | 6.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.8 | 6.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.7 | 3.7 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.7 | 12.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.7 | 5.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.7 | 7.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.7 | 2.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.7 | 9.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.7 | 2.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.7 | 20.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.7 | 12.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.6 | 8.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.6 | 2.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.6 | 4.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.6 | 5.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.6 | 3.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.6 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 5.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.6 | 4.5 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.6 | 4.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.6 | 5.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.5 | 7.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 4.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 7.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 2.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.5 | 8.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 37.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.5 | 3.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.5 | 6.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 5.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.5 | 6.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 80.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.5 | 4.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.5 | 30.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.5 | 1.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 6.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.5 | 0.9 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.5 | 3.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.5 | 6.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.5 | 1.4 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.5 | 4.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 3.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 9.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 7.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 5.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 2.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.4 | 2.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.4 | 0.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.4 | 11.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 3.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 6.1 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.4 | 1.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.4 | 4.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 3.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 2.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 2.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 3.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.4 | 3.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 8.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.4 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 8.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 4.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 12.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.4 | 2.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 9.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.4 | 14.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 1.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 3.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 2.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 15.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.3 | 14.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 5.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.3 | 7.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 5.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 3.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 7.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 4.0 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.3 | 10.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 3.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 5.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 4.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 1.2 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.2 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 2.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 2.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 0.4 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.2 | 2.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 2.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.2 | 2.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 3.8 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.2 | 2.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 4.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 4.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 15.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 2.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 6.5 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.2 | 3.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 1.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 1.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 0.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 1.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 2.1 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.2 | 0.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 1.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.4 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 1.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 2.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 8.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 1.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 2.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 2.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.4 | REACTOME GLYCOSAMINOGLYCAN METABOLISM | Genes involved in Glycosaminoglycan metabolism |
0.0 | 0.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.2 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 0.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 1.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |